Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

GomSpace Group AB proposes two new candidates for Board of Directors

GomSpace Group AB Nomination Committee proposes two new candidates for the Board of Directors to be elected at the upcoming Annual General Meeting on May 31.Today, the members of the Nomination Committee are Stefan Gardefjord, appointed by Longbus Holding and Henrik Kølle, appointed by Peter Hargreaves, whereas Stefan Gardefjord is appointed as chairman. The committee aims to ensure that the composition of the board of directors is optimally aligned to the company’s operations, stage of development, and other conditions in general, by leveraging the board members’ combined expertise and

Invitation to Immunovia’s Q1 presentation

LUND (SWEDEN) – Immunovia will publish its first quarter 2023 results on May 23, 2023 at 8:30 am CET. Analysts, investors and media are invited to a webcast teleconference on the same day at 15:00 CET. The report together with the presentation slides will be available at www.immunovia.com   Jeff Borcherding, CEO and President, and Karin Almqvist Liwendahl, CFO, will present on Immunovia’s development. The presentation will be held in English and be followed by a Q&A session. You are welcome to join via webcast or phone, see details below.   Telephone numbers and webcast Call

Navian Launches Exclusive Forum for Real Estate Development Investors

Navian Tech, winner of the 2023 Nordic PropTech Awards  in the Invest & Finance category, has launched a forum with exclusive gatherings for professional investors in the real estate develompment industry.The exclusive meetings will focus on sharing and discussing proven strategies for real estate development transactions, as well as providing insights and opportunities to participate in attractive off-market investment deals. By utilising a combination of proven strategies and staying updated with relevant information, investors will be

BioStock: Highlights from SynAct Pharma’s Capital Markets Day

On May 5, SynAct Pharma held a Capital Markets Day in Stockholm featuring presentations from the management team, as well as Key Opinion Leaders in inflammation resolution and rheumatoid arthritis. The presentations highlighted the unmet medical need in rheumatoid arthritis and validated the potential of SynAct Pharma’s drug candidate resomelagon in that area, but also in other diseases characterised by inflammation. BioStock contacted Torbjørn Bjerke to hear his highlights from the day.Read the full article at biostock.se: https://www.biostock.se/en/2023/05/highlights-from-synact-

Best practices from Metsä Group’s nature programme shared in Lohja

On 16 May, the coordinators of projects funded by Metsä Group’s nature programme met in Kirkniemi in Lohja to network and share their experiences of the increasingly varied nature restoration methods. Events organised for project coordinators are an excellent opportunity to jointly develop a new operating culture, in which community spirit helps strengthen nature. This first event brought together the coordinators of projects funded in 2022 across Finland.   Metsä Group’s nature programme is a long-term funding scheme for projects focused on the management and restoration of Finnish

Advenica publishes English version of the annual report for 2022

Advenica has published a shorter, English version of the company's annual report for the business year 2022. The report is available on the company's website ! For further information, please contact:Marie Bengtsson, VD Advenica AB, +46 (0) 703 860 032, marie.bengtsson@advenica.com The information was submitted for publication, through the agency of the contact person set out above, at 10.20 CET on May 17th, 2023.

SeaDrain White – the thermoplastic black and grey water drainage system with two jointing technologies

The polypropylene drainage piping system is lighter in weight, lighter on maintenance requirements, lighter on installation time and labor, and lighter in lifetime system costs than competing metal systems. SeaDrain White is a paint- and corrosion-free system and was introduced to the market in 2020. Since it's market introduction, GF Piping Systems has collected customer feedback and has used the past months to further optimize SeaDrain White for the customer's needs.The SeaDrain White grey and black water system is suitable for any type of ship, but it is particularly popular in the

Communiqué from the Annual General Meeting 2023 of Bricknode Holding AB (publ)

The Annual General Meeting of Bricknode Holding AB (publ) was held on 17 May 2023.Income statements and balance sheets The Meeting adopted the income statement and the balance sheet for the parent company as well as the consolidated income statement and the consolidated balance sheet for 2022. Dispositions of the Company's results The Meeting resolved, in accordance with the Board's proposal, that this year’s loss of SEK 1,010,525 is to be carried forward. Discharge from liability The members of the Board of Directors and the CEO were discharged from liability for their

The Board of Directors of Moberg Pharma has resolved on record date for the reverse share split

The Annual General Meeting in Moberg Pharma AB (publ) (“Moberg Pharma” or the “Company”) on 16 May 2023 resolved on a reverse share split, through which ten existing shares will be consolidated into one share (Sw: Sammanläggning 1:10). The Board of Directors was authorized by the Annual General Meeting to resolve on the record date for the reverse share split. The Board of Directors now resolved that the record date for the reverse share split will be 25 May 2023.The Board of Directors' resolution means that the last day of trading in Moberg Pharma's share prior to the reverse share split

UIE's First Quarter Report 2023

On Wednesday, 17 May 2023, UIE Plc. announced its financial results for the first quarter of 2023. Highlights from Q1 2023: · UIE's net result was USD 32.4 million in the first quarter of 2023, which is USD 51.9 million higher than the net loss of USD 19.5 million reported in the first quarter of 2022. · The share of UP’s net profit was USD 12.1 million in the first quarter of 2023, which was significantly higher than the USD 6.9 million reported in the first quarter of 2022. This was achieved despite a lower contribution from the plantation division. The higher net result in UP

WindowMaster International wins OEM contract order from leading German skylight manufacturer

Investor News No. 004 - 2023 WindowMaster has won another contract order from one of Europe’s market leading skylight manufacturers. It includes the supply of large actuators – a product type in which WindowMaster is a market leader due to its quality, strength, and reliability. The order can also be attributed to the solid delivery performance ensured by our production in Herford. The order exemplifies yet again why the market-leading skylight manufacturers chose WindowMaster as their trusted OEM supplier. The skylight with our motor was launched last month at the world’

Company Announcement no. 50, 2023 – Nordea Kredit Realkreditaktieselskab drawings as per 1 July 2023

Nordea Kredit hereby announces drawings data for callable covered mortgage bonds (SDRO) as per 1 July 2023. The figures are published in order to comply with publication requirements in the transparency regulation 2017/1129/EU and the Danish Act on Capital Markets section 24. Questions can be directed to Torben Jurlander phone +45 55 47 41 99.     Yours faithfully   Nordea Kredit Realkreditaktieselskab

BioStock: Arcede approaching dosing in tox study

When reporting on first quarter of 2023, Arcede Pharma have an eventful period to look back on. Now all eyes are on the final part of the toxicology programme, where dosing starts in June. BioStock contacted CEO Mia Lundblad to hear her thoughts on the past quarter.Read the full article at biostock.se : https://www.biostock.se/en/2023/05/arcede-approaching-dosing-in-tox-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Crayfish BidCo Oy extends the offer period under the voluntary recommended cash tender offer for all shares in Caverion Corporation until 31 July 2023

Caverion Corporation   Tender Offer   17 May 2023 at 10.05 a.m. EESTCrayfish BidCo Oy extends the offer period under the voluntary recommended cash tender offer for all shares in Caverion Corporation until 31 July 2023 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION, PLEASE SEE SECTION ENTITLED “IMPORTANT INFORMATION” BELOW. On 10 January 2023, Crayfish

Gradientech: Interim report 1 January – 31 March 2023

Gradientech AB (publ) interim report for Q1 2023 is now available on the company's website www.gradientech.se.First quarter January-March 2023 · Net sales amounted to KSEK 380 (0). · Profit after tax amounted to KSEK -18,063 (-15,171). · Earnings per share before and after dilution were SEK -1.08 (-1.04). · Cash flow from operating activities amounted to KSEK -18,068 (-14,982). · Cash and cash equivalents on the balance sheet date amounted to KSEK 25,993 (74,020). · Equity as of March 31, 2023 amounted to KSEK 40,731 (78,598). · On January 18, 2023, the subscription

KPMG Iceland in collaboration with DecideAct: Efficient strategy implementation is the key to success

KPMG in Iceland and the software company DecideAct have signed a partnership agreement that will increase the level of service for KPMG Iceland's clients. The cooperation consists of, among other things, the results of strategic work and action plans that will be delivered ready for implementation in the DecideAct software.The strategy execution software has been developed for over 10 years and is a powerful solution for companies and organizations that want to ensure progress and effective strategy implementation. DecideAct is listed on the Nasdaq First North Growth Market in Denmark and

Valmet to supply consistency measurements to Norske Skog in France

Valmet Oyj’s trade press release on May 17, 2023 at 10:00 a.m. EESTValmet will supply consistency measurements to Norske Skog’s Golbey mill in France. The new measurements will be implemented in the new stock preparation unit and replace the aged ones from Golbey’s PM 1, which is currently being converted from the production of newsprint to the production of recycled containerboard. The order was included in Valmet’s orders received of the first quarter 2023. The measurements were delivered during the first quarter of 2023. The value of the order will not be disclosed. “We have

UPM Raflatac showcases its Graphics Solutions at FESPA Global Print Expo 2023

(UPM Raflatac, Helsinki, 17 May 2023 at 10:00 EEST) – UPM Raflatac, a global supplier of innovative and sustainable self-adhesive paper and film products, will showcase its graphics solutions at FESPA Global Print Expo 2023 in Munich, Germany on 23-26 May. UPM Raflatac will be participating in the expo for the first time under the Intercoat by UPM Raflatac brand name, after having acquired the AMC AG and the Intercoat brand in 2022. At their booth, UPM Raflatac will exhibit the UPM Raflatac Graphics Solutions, such as their PVC-free Eco Collection, Smart Apply Collection for fast and

Inify Laboratories AB (publ) – summary of Annual General Meeting

Inify Laboratories AB, corp. no. 559345-4431, held its ordinary Shareholders’ Annual General Meeting at the company's premises on May 16, 2023. A total of 34,075,774 shares were represented at the Annual General Meeting, corresponding to 75.3% of the total number of shares and votes. The AGM resolved, with the required majority, on all matters in accordance with the Board of Directors's published proposal. Below is a summary of the main decisions made, for further details please refer to the notice available on the company's website.   Adoption of the accounts The Annual General

Helsinki Paves the Way as a Forerunner of Circular Business when World Circular Economy Forum Returns Home

The circular economy has great potential at different stages of construction. The Helsinki Cluster Programme for Circular Economy carried out a reuse pilot at Katajanokka pier. It involved the transfer of usable furniture and materials from the demolition site to be reused elsewhere before the demolition work started. Photo: Kari Ylitalo The World Circular Economy Forum WCEF2023 will take place in Helsinki, Finland, from 30 May to 2 June 2023. The forum brings together the world's leading circular economy players to present and seek business and government solutions. It’s widely

BioStock: Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation

Chronic inflammation is an underlying cause of many diseases and represents an immense societal burden. Researchers continue to struggle to solve the riddle behind this mechanism, and still treatments are lacking. Confronting the issue is the Swedish biotech Aqilion. BioStock spoke with the company's CEO Sarah Fredriksson to learn more about Aqilion’s vision and mission.Read the interview with Aqilion's CEO Sarah Fredriksson at biostock.se: Aqilion – Disrupting the Vicious Cycle of Chronic Inflammation - BioStock 

Carbiotix decides to scale up the production of CarbiAXOS from oat fiber

Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company has decided to scale up the production of CarbiAXOS from oat fiber at its production site in Bjuv. The oat fiber is supplied by The Green Dairy Sweden AB (“The Green Dairy”) based in Karlshamn, Sweden, and dried utilizing a technology provided by Elajo Technology Solutions AB (“Elajo”) based in Oskarshamn, Sweden. This decision to scale up the production of CarbiAXOS based on oats follows a successful 9-month evaluation project originally communicated on the 30th of March 2022. Successfully sourcing and upcycling

Dicot's study drug has arrived in Sweden

Press release: Uppsala, May 17, 2023. In preparation for Dicot's phase 1 clinical trial, the study drug to be used has now been manufactured by Thermo Fisher Scientific and arrived in Sweden.In February, the contract manufacturer Thermo Fisher Scientific began producing the study drug to be used when Dicot enters clinical trials with its potency drug candidate, which is planned for August this year. The manufacturing, done according to Good Manufacturing Practice, has now been completed and the study drug has arrived in Sweden. Study drug with active substance as well as matching placebo

Collaboration is key to creating a culture that supports children’s behaviour in early childhood education

When a child behaves in an unwanted manner, changing their behaviour often becomes a focus. Research, however, suggests that influencing the behaviour of adults who interact with the child would be more effective. Researchers at the University of Eastern Finland and the University of Jyväskylä conducted an 18-month follow-up of 18 Finnish early childhood education and care (ECEC) centres that were piloting positive behaviour intervention and support (PBIS), which takes a research-based approach to creating an operational culture that supports the behaviour of all children. The PBIS

There are no items matching the current filter
There are no more items matching the current filter
Back to top